Home/Corbus Pharmaceuticals/Dr. Dominic Smethurst, MA MRCP
DD

Dr. Dominic Smethurst, MA MRCP

Chief Medical Officer

Corbus Pharmaceuticals

Therapeutic Areas

Corbus Pharmaceuticals Pipeline

DrugIndicationPhase
CRB-701Nectin-4 expressing solid tumors (e.g., Cervical Cancer, HNSCC, mUC)Phase 1
CRB-913Obesity and related conditionsPhase 1